Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Codagenix
3145
Codagenix
Technology
Biotechnology
Designer Viruses ~ Vaccine Development ~ Synthetic Biology ~ Ultra Low Dose Influenza Vaccines ~ Customized Dengue
Suggest edits
Type
B2c
Founded
2011
Raised
$26M
Follow us
Companies in the same industry
InflaRx
numares AG
Biome Makers
ProteoMediX
Gobiquity
Recros Medica
Avitide, Inc.
Securus Medical Group
Avadim Technologies, Inc.
Fortis Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Latest funding
Show all
$20,000,000
Venture capital - 2020
Topspin Fund
Topspin Partners
Euclidean Capital
+1
$3,000,000
Venture capital - 2017
Topspin Partners
Team Size
2
Employees
I work here
Location
United States
Headquarters
Explore United States
FinSMEs
Codagenix Raises $20M in Series B Funding
$20,000,000
Venture capital
TechCrunch
Codagenix raises $20 million for a new flu vaccine and other therapies
$2,000,000
Venture capital (Series A)
Xconomy
With $2M, Codagenix Becomes Accelerate LI’s First VC-Backed Grad
Funding
Health
